Iconic Labs PLC - Interim Results
Iconic Labs PLC
("Iconic" or the "Company")
Interim results for the six months ended 31 December 2025
Iconic Labs PLC (LSE: ICON), today announces its unaudited financial results for the six-month period ended 31 December 2025.
This announcement contains information which, prior to its disclosure, was inside information as stipulated under Regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310 (as amended).
For any further information or enquiries please contact:
|
Iconic Labs John Farquharson, Chief Executive Officer |
via Yellow Jersey PR |
|
AlbR Capital Limited David Coffman / Daniel Harris |
Tel: +44 (0) 20 7469 0930
|
|
Yellow Jersey PR Charles Goodwin Annabelle Wills
|
Tel: +44 (0) 20 3004 9512
|
CHIEF EXECUTIVE OFFICER'S STATEMENT
I am pleased to present the interim unaudited accounts for the six-month period ended
The Company is focusing all of its time, resources, and energy on acquiring a suitable target through a reverse takeover ("RTO") to generate long-term growth and value for its shareholders.
While there are numerous businesses interested in being listed on the Main Market of the London Stock Exchange, identifying suitable targets takes a significant amount of time and resources. At the outset, any acquisition target must meet the minimum market capitalisation requirement of
We look forward to providing updates in due course.
GOING CONCERN ASSESSMENT
The Board has carefully considered the financial position of Iconic regarding the events during the six months ended
In the event that such a target cannot be identified within a short period of time, it is possible that the investor will cease to provide funding. Although the Directors would endeavor to pursue alternative sources of funding, there is no certainty that this could be achieved. In such an event Iconic would need to wind down its operations, realise any assets and may enter administration, if and to the extent there are creditors of the Company who cannot be paid. In such an event, Iconic would no longer manage its affairs or the realisation of its assets. As a result of either winding down the business or entering into administration, the Ordinary Shares would be cancelled from the Official List and Shareholders may receive little or no value for their Ordinary Shares.
On this basis, there is a material uncertainty related to events or conditions that may cast significant doubt on the Company's ability to continue as a going concern and that it may therefore be unable to realise its assets and discharge its liabilities in the normal course of business. However, the Directors believe it remains appropriate to prepare the financial statements on a going concern basis.
PRINCIPAL RISKS AND UNCERTAINTIES
The following risks are considered by the Board to be the most significant to the business:
Going Concern Risk
Iconic's strategy continues to focus on finding a suitable target. If an alternative target is not found within a reasonable period of time, there is a risk that further funding may not be made available from the existing investor and that whilst the on-going running cost of the Company is expected to be low, the Company may not be able to meet its liabilities as they fall due.
Revenue, Profitability and Funding Risk
Iconic currently only has one asset, Gay Star News ("GSN"), an online media platform, which is not cash-generative, and therefore, Iconic currently generates no revenues. The Company has been reliant upon the issuance of promissory notes for its main source of working capital.
Dilution and Pricing Risk
If the holders of the Company's convertible loan notes and warrants exercise their full conversion rights, this could result in them owning a significant holding in the Company. However, the holders' strategy is generally to sell shares in the market as soon as practicable following the exercise of such rights. Accordingly, there is a risk that should the loan note holders exercise and sell shares in significant amounts over a lengthy period, this could have a material negative impact on the price of the shares.
Financial Risk Management
The Board monitors the internal risk management function across Iconic and advises on all relevant risk issues. There is regular communication with external advisors and regulators.
FINANCIAL REVIEW
Iconic made a loss in the 6 month period of
At
Key Performance Indicators
The business is focused on the areas of cash management and operating results.
RESPONSIBILITY STATEMENT
The directors confirm to the best of our knowledge:
• the interim financial statements have been prepared in accordance with IAS 34, as adopted by the United Kingdom;
• the Chairman's statement and interim financial statements include a fair review of the information required by the Financial Statements Disclosure and Transparency Rules (DTR) 4.2.7R, being an indication of important events that have occurred during the first six months of the financial year and a description of the principal risks and uncertainties for the remaining six months of the year; and
• the Chairman's statement includes a fair review of the information required by DTR 4.2.8R, being related party transactions that have taken place in the first six months of the current financial year and that have materially affected the financial position or performance of the entity during the period and also any changes in the related party transactions described in the last annual report that could do so.
At the date of this statement, the Directors are those listed on the Company information page of these interim financial statements.
CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME FOR THE SIX MONTHS ENDED
|
|
|
Six months ended 31 December 2025 |
|
Six months ended 31 December 2024 |
|
Year ended |
|
|
|
£ |
|
£ |
|
£ |
|
|
|
|
|
|
|
|
|
Revenue |
|
- |
|
- |
|
- |
|
|
|
|
|
|
|
|
|
Gross profit |
|
- |
|
- |
|
- |
|
|
|
|
|
|
|
|
|
Administrative expenses |
|
(236,165) |
|
(201,371) |
|
(555,119) |
|
Direct costs incurred in connection with financing facility |
|
- |
|
(60,000) |
|
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating loss |
|
(236,165) |
|
(261,371) |
|
(555,119) |
|
|
|
|
|
|
|
|
|
Finance costs |
|
(33,665) |
|
(32,309) |
|
(64,214) |
|
|
|
|
|
|
|
|
|
Loss before taxation |
|
(269,830) |
|
(293,680) |
|
(619,333) |
|
|
|
|
|
|
|
|
|
Taxation |
|
- |
|
- |
|
(8,892) |
|
|
|
|
|
|
|
|
|
Loss for the period |
(269,830) |
|
(293,680) |
|
(628,225) |
|
|
|
|
|
|
|
|
|
|
Total comprehensive expense for the period |
(269,830) |
|
(293,680) |
|
(628,225) |
|
|
Basic and diluted loss per ordinary share for continuing operations (pence) |
|
(1.94) |
|
(2.63) |
|
(5.53) |
The loss for the period is wholly attributable to the equity holders of the parent company.
All operations of the group are continuing.
CONSOLIDATED STATEMENT OF FINANCIAL POSITION AT
|
|
|
Six months ended |
|
Six months ended |
|
Year ended |
|
|
Notes |
£ |
|
£ |
|
£ |
|
|
|
|
|
|
|
|
|
Non-current assets |
|
|
|
|
|
|
|
Intangible assets |
|
1 |
|
1 |
|
1 |
|
|
|
|
|
|
|
|
|
|
|
1 |
|
1 |
|
1 |
|
|
|
|
|
|
|
|
|
Current assets |
|
|
|
|
|
|
|
Trade and other receivables |
|
4,397 |
|
35,860 |
|
59,305 |
|
Cash and cash equivalents |
|
8,982 |
|
49,288 |
|
35,738 |
|
|
|
|
|
|
|
|
|
|
|
13,379 |
|
85,148 |
|
95,043 |
|
|
|
|
|
|
|
|
|
Total assets |
|
13,380 |
|
85,149 |
|
95,044 |
|
|
|
|
|
|
|
|
|
Equity |
|
|
|
|
|
|
|
Shareholders' equity |
|
|
|
|
|
|
|
Share capital |
3 |
5,192,874 |
|
5,192,602 |
|
5,192,874 |
|
Share premium |
|
8,450,316 |
|
8,401,588 |
|
8,450,316 |
|
Retained deficit |
|
(17,875,288) |
|
(17,270,913) |
|
(17,605,458) |
|
|
|
|
|
|
|
|
|
Total equity |
|
(4,232,098) |
|
(3,676,723) |
|
(3,962,268) |
|
|
|
|
|
|
|
|
|
Current liabilities |
|
|
|
|
|
|
|
Trade and other payables |
4 |
969,325 |
|
806,289 |
|
980,824 |
|
Loans and borrowings |
|
3,276,153 |
|
2,955,583 |
|
3,076,488 |
|
|
|
|
|
|
|
|
|
|
|
4,245,478 |
|
3,761,872 |
|
4,057,312 |
|
|
|
|
|
|
|
|
|
Total liabilities |
|
4,245,478 |
|
3,761,872 |
|
4,057,312 |
|
|
|
|
|
|
|
|
|
Total equity and liabilities |
|
13,380 |
|
85,149 |
|
95,044 |
|
|
|
|
|
|
|
|
|
Net asset value per share (pence) |
|
(30.48) |
|
(32.94) |
|
(28.54)
|
CONSOLIDATED STATEMENT OF CHANGES IN EQUITY FOR THE SIX MONTHS ENDED
|
|
Share capital £ |
Share premium £ |
Retained deficit £ |
Total equity £ |
|
Balance at |
5,192,602 |
8,401,588 |
(16,977,233) |
(3,383,043) |
|
|
|
|
|
|
|
Total comprehensive expense |
- |
- |
(293,680) |
(293,680) |
|
Balance at |
5,192,602 |
8,401,588 |
(17,270,913) |
(3,676,723) |
|
|
|
|
|
|
|
Changes in equity |
|
|
|
|
|
Transactions with owners: |
|
|
|
|
|
Issue of shares |
272 |
48,728 |
- |
49,000 |
|
Total transactions with owners: |
272 |
48,728 |
- |
49,000 |
|
Total comprehensive expense |
- |
- |
(334,545) |
(334,545) |
|
Balance at |
5,192,874 |
8,450,316 |
(17,605,458) |
(3,962,268) |
|
Total comprehensive expense |
- |
- |
(269,830) |
(269,830) |
|
Balance at |
5,192,874 |
8,450,316 |
(17,875,288) |
(4,232,098) |
CONSOLIDATED STATEMENT OF CASH FLOWS FOR THE SIX MONTHS ENDED
|
|
|
Six months ended 31 December 2025 |
|
Six months ended |
|
Year ended |
|
|
|
|
£ |
|
£ |
|
£ |
|
|
Cash flows from operating activities |
|
|
|
|
|
|
|
|
Total comprehensive expense for the period |
(269,830) |
|
(293,680) |
|
(628,225) |
|
|
|
Costs relating to financing facility |
- |
|
60,000 |
|
120,000 |
|
|
|
Interest on promissory notes |
33,665 |
|
32,309 |
|
64,214 |
|
|
|
Tax charge |
- |
|
- |
|
8,892 |
|
|
|
Adjustments for |
|
|
|
|
|
|
|
|
Decrease/(Increase) in trade and other receivables |
|
54,908 |
|
(25,830) |
|
(49,275) |
|
|
(Decrease)/Increase in trade and other payables |
|
(11,499) |
|
(69,315) |
|
36,328 |
|
|
|
|
|
|
|
|
|
|
|
Net cash used in by operating activities |
|
(192,756) |
|
(296,516) |
|
(448,066) |
|
|
|
|
|
|
|
|
|
|
|
Cash flows from financing activities |
|
|
|
|
|
|
|
|
Issue of promissory notes |
|
166,000 |
|
216,495 |
|
354,495 |
|
|
|
|
|
|
|
|
|
|
|
Net cash generated by financing activities |
|
166,000 |
|
216,495 |
|
354,495 |
|
|
|
|
|
|
|
|
|
|
|
Decrease in cash and cash equivalents |
|
(26,756) |
|
(80,021) |
|
(93,571) |
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents at beginning of period |
|
35,738 |
|
129,309 |
|
129,309 |
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents at end of period |
|
8,982 |
|
49,288 |
|
35,738 |
|
COMPANY STATEMENT OF FINANCIAL POSITION AT
|
|
|
Six months ended |
|
Six months ended |
|
Year ended |
|
|
|
£ |
|
£ |
|
£ |
|
|
|
|
|
|
|
|
|
Non-current assets |
|
|
|
|
|
|
|
Investments |
1 |
|
1 |
|
1 |
|
|
Non-current assets |
|
1 |
|
1 |
|
1 |
|
Current Assets |
|
|
|
|
|
|
|
Trade and other receivables |
|
4,397 |
|
35,860 |
|
59,305 |
|
Cash and cash equivalents |
|
8,982 |
|
49,288 |
|
35,738 |
|
|
|
13,379 |
|
85,148 |
|
95,043 |
|
|
|
|
|
|
|
|
|
Total assets |
|
13,380 |
|
85,149 |
|
95,044 |
|
|
|
|
|
|
|
|
|
Equity |
|
|
|
|
|
|
|
Share capital |
|
5,192,874 |
|
5,192,602 |
|
5,192,874 |
|
Share premium |
|
8,450,316 |
|
8,401,588 |
|
8,450,316 |
|
Retained deficit |
|
(17,875,288) |
|
(17,270,913) |
|
(17,605,458) |
|
|
|
(4,232,098) |
|
(3,676,723) |
|
(3,962,268) |
|
|
|
|
|
|
|
|
|
Current liabilities |
|
|
|
|
|
|
|
Trade and other payables |
|
969,325 |
|
806,289 |
|
980,824 |
|
Loans and borrowings |
|
3,276,153 |
|
2,955,583 |
|
3,076,488 |
|
|
|
4,245,478 |
|
3,761,872 |
|
4,057,312 |
|
|
|
|
|
|
|
|
|
Total liabilities |
|
4,245,478 |
|
3,761,872 |
|
4,057,312 |
|
|
|
|
|
|
|
|
|
Total equity and liabilities |
|
13,380 |
|
85,149 |
|
95,044 |
|
|
|
|
|
|
|
|
COMPANY STATEMENT OF CHANGES IN EQUITY FOR THE SIX MONTHS ENDED
|
|
Share capital £ |
Share premium £ |
Retained deficit £ |
Total equity £ |
|
Balance at |
5,192,602 |
8,401,588 |
(16,977,233) |
(3,383,043) |
|
|
|
|
|
|
|
Total comprehensive expense |
- |
- |
(293,680) |
(293,680) |
|
Balance at |
5,192,602 |
8,401,588 |
(17,270,913) |
(3,676,723) |
|
|
|
|
|
|
|
Changes in equity |
|
|
|
|
|
Transactions with owners: |
|
|
|
|
|
Issue of shares |
272 |
48,728 |
- |
49,000 |
|
Total transactions with owners: |
272 |
48,728 |
- |
49,000 |
|
Total comprehensive expense |
- |
- |
(334,545) |
(334,545) |
|
Balance at |
5,192,874 |
8,450,316 |
(17,605,458) |
(3,962,268) |
|
Total comprehensive expense |
- |
- |
(269,830) |
(269,830) |
|
Balance at |
5,192,874 |
8,450,316 |
(17,875,288) |
(4,232,098) |
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE SIX MONTHS ENDED
1. Basis of preparation
The Company is registered in England and Wales. The consolidated interim financial statements for the six months ended
Statement of compliance
This consolidated interim financial report has been prepared in accordance with the measurement principles of IFRS adopted in the United Kingdom. Selected explanatory notes are included to explain events and transactions that are significant to an understanding of the changes in financial performance and position of the Company since the last annual consolidated financial statements for the year ended
A copy of the audited annual report for the period ended
This consolidated interim financial report was approved by the Board of Directors on
Significant accounting policies
The accounting policies applied by the Company in this consolidated interim financial report are the same as those applied by the Company in its consolidated financial statements for the period ended
New and amended standards adopted by the Company
A number of new or amended standards became applicable for the current reporting period. The Company did not have to change its accounting policies or make retrospective adjustments as a result of the adoption of these standards.
Going concern
The Board of Directors has carefully considered the financial position of Iconic Labs regarding the events during the six months ended
2. Operating segments
The Company's sole asset is Gay Star News ("GSN"), an online media platform dedicated to the LGBTQ+ community. GSN generates no revenue for the Group.
3. Share capital
|
|
|
|
|
||
|
|
Number |
£ |
Number |
£ |
|
|
Allotted, issued and fully paid: |
|
|
|
|
|
|
Classified as equity |
|
|
|
|
|
|
Ordinary shares of |
13,884,027 |
1,388 |
13,884,027 |
1,388 |
|
|
Deferred shares of |
11,161,483 |
1,115,032 |
11,161,483 |
1,115,032 |
|
|
Deferred shares of |
1,637,129,905 |
4,076,454 |
1,637,129,905 |
4,076,454 |
|
|
Total |
1,662,175,415 |
5,192,874 |
1,662,175,415 |
5,192,874 |
|
|
|
|||||
In accordance with the Companies Act 2006, the Company has no limit on its authorised share capital.
4. Trade and other payables
Group
|
|
|
|
30 June 2025 (audited) |
|
|
£ |
£ |
£ |
|
Trade payables |
693,247 |
774,056 |
719,872 |
|
Other payables |
- |
(11,942) |
- |
|
Accruals |
276,078 |
44,175 |
260,952 |
|
|
969,325 |
806,289 |
980,824 |
|
|
|
|
|
Company
|
|
|
|
30 June 2025 (audited) |
|
|
£ |
£ |
£ |
|
Trade payables |
693,247 |
774,056 |
719,872 |
|
Other payables |
- |
(11,942) |
- |
|
Accruals |
276,078 |
44,175 |
260,952 |
|
|
969,325 |
806,289 |
980,824 |
Book values approximate to fair values at
5. Loans and borrowings
Group
|
|
|
|
30 June 2025 (audited) |
|
|
£ |
£ |
£ |
|
Promissory notes |
1,250,153 |
880,583 |
1,050,488 |
|
Convertible loans |
2,026,000 |
2,075,000 |
2,026,000 |
|
|
3,276,153 |
2,955,583 |
3,076,488 |
|
|
|
|
|
Company
|
|
|
|
30 June 2025 (audited) |
|
|
£ |
£ |
£ |
|
Promissory notes |
1,250,153 |
880,583 |
1,050,488 |
|
Convertible loans |
2,026,000 |
2,075,000 |
2,026,000 |
|
|
3,276,153 |
2,955,583 |
3,076,488 |
Promissory notes
The Company issued a further
6. Financial instruments
Reconciliation of movement in net cash
|
|
Net cash at |
Cash flow |
Promissory notes issued in the period |
Accrued interest on promissory notes |
Loan notes issued in the period |
Net cash at 31 December 2025 |
|
||
|
|
£ |
£ |
£ |
£ |
£ |
£ |
|
||
|
Cash at bank and in hand |
35,738 |
(26,756) |
- |
- |
|
8,982 |
|
||
|
Borrowings |
(3,076,488) |
- |
(166,000) |
(33,665) |
- |
(3,276,153) |
|
||
|
|
|
|
|
|
|
|
|
||
|
Total financial liabilities |
(3,040,750) |
(26,756) |
(166,000) |
(33,665) |
- |
(3,267,171) |
|
||
|
|
|
|
|
|
|
|
|||
7. Loss from Operations
|
|
|
Period ending 31 December 2025 |
Period ending 31 December 2024 |
Year ended 30 June 2025 (audited) |
|
|
|
£ |
£ |
£ |
|
The loss for the period is stated after charging: |
|
|
|
|
|
Auditors' remuneration - audit services |
12,000 |
15,000 |
24,000 |
|
|
|
|
|
|
|
|
Expenses by Nature: |
£ |
£ |
£ |
|
|
Legal & audit fees |
90,096 |
79,452 |
188,903 |
|
|
Consultancy & professional fees |
67,525 |
91,942 |
42,817 |
|
|
Other supplies and external services |
78,544 |
29,977 |
323,399 |
|
|
|
|
|
|
|
|
Total operating expenses |
236,165 |
201,371 |
555,119 |
|
|
Total administrative expense |
236,165 |
201,371 |
555,119 |
|
|
Interest on promissory notes |
33,665 |
32,309 |
64,214 |
|
|
Direct costs incurred in connection with financing facilities |
- |
60,000 |
- |
|
|
|
|
|
|
|
|
|
|
269,830 |
293,680 |
619,333 |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Proactive Investors is a publisher of financial news and information. No content in this record, or published on the Proactive Investors website (the "Site"), constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. No content is tailored to any specific person's needs, objectives, or financial situation.
Proactive Investors is not registered in any category of registration under the securities legislation of any province or territory of Canada. Nothing in this record constitutes "advice" concerning investing in, buying, or selling a security within the meaning of applicable Canadian securities legislation. None of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value, or suitability of any particular security, portfolio, transaction, or investment strategy. Any decision to buy, sell, or hold a security should be made only after obtaining advice from a registrant authorised under the securities legislation of your province or territory.
This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell any product or security. Our content is independent financial journalism, produced in a neutral, objective style with full source attribution. Where Proactive Investors has a commercial relationship with a company covered in this record, that relationship is disclosed within the article. Any such relationship is for news distribution and media services only and does not determine, influence, or shape the editorial content produced.
The Site may contain opinions from time to time regarding securities mentioned in other products, including company-related products, and those opinions may differ from those obtained through another Proactive Investors product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.
Price and other data is supplied by sources believed to be reliable. Any calculations are made using such data. Neither the data nor the calculations are guaranteed by those sources, by Proactive Investors, by the information providers, or by any other person or entity, and may not be complete or accurate.
From time to time, reference may be made in our marketing materials to previously published articles or opinions. Such references may be selective, may reference only a portion of an article, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.
FOR OUR FULL DISCLAIMER CLICK HERE